RIV.V - Canopy Rivers Inc.

TSXV - TSXV Delayed Price. Currency in CAD
2.3800
+0.0600 (+2.59%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close2.3200
Open2.4000
Bid2.3500 x 0
Ask2.4100 x 0
Day's Range2.3400 - 2.5000
52 Week Range0.1550 - 6.3300
Volume363,501
Avg. Volume373,473
Market Cap445.203M
Beta (3Y Monthly)N/A
PE Ratio (TTM)119.00
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Market Exclusive

    Canopy Rivers Gets Approval to Expand Ontario’s Production Facility

    Canopy Rivers (TSXV: RIV) (OTC: CNPOF) announced that its portfolio company Radicle Medical Marijuana received approval from Health Canada to expand its production facility in Ontario. The approval will help the company to effectively double its production, increasing its capacity to 6,000 kilograms per year. With the Health Canada approval, Radicle will have 40,000 sq. […]The post Canopy Rivers Gets Approval to Expand Ontario’s Production Facility appeared first on Market Exclusive.

  • Cannabis Investors: The One Stock That All Investors Should Own
    The Motley Fool

    Cannabis Investors: The One Stock That All Investors Should Own

    Canopy Rivers Inc (TSXV:RIV) the venture capital arm of Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has a unique business model that ensures it will grow along with the cannabis industry.

  • Could This Canopy Growth (TSX:WEED) Spin-Off Be a Great Buy?
    The Motley Fool

    Could This Canopy Growth (TSX:WEED) Spin-Off Be a Great Buy?

    Canopy Rivers Inc. (TSXV:RIV) has an interesting business strategy and could benefit substantially from the growing marijuana market. But is it a buy right now?

  • Cannabis venture capital firm Canopy Rivers reports $1.8-million Q4 loss
    The Canadian Press

    Cannabis venture capital firm Canopy Rivers reports $1.8-million Q4 loss

    Canopy Rivers Inc., the venture capital arm of cannabis company Canopy Growth Corp., swung to a loss in its latest quarter as its operating expenses soared. The Toronto-based firm reported Tuesday a loss of $1.8 million in the three months ended March 31 compared with a profit of nearly $14.6 million in the same quarter last year. Canopy Rivers said as positive global sentiment towards pot rises and Canada legalizes edibles, topicals and extracts, there is growth potential for the industry and ancillary businesses which do not touch the plant.

  • Market Exclusive

    Cannabis Stock News Daily Roundup July 10

    Zenabis Global (OTCMKTS:ZBISF) has submitted its site evidence package to Health Canada for the first phase of its facility in Langley. Called Zenabis Langley, the facility’s first 50,000 sq. ft. flower room is substantially complete, while work on the remaining five flower rooms and additional support space, totaling 380,000 sq. ft., is set to complete […]The post Cannabis Stock News Daily Roundup July 10 appeared first on Market Exclusive.

  • Market Exclusive

    Cannabis Stock News Daily Roundup July 5

    Cannabis Stock News The Cannabis Council of Canada (C3) applauded the Government of Ontario for their decision to expand adult use retail cannabis licenses. With national cannabis supply levels improving, C3 believes that the continued and sustained expansion of Ontario's retail network will be a key factor in replacing the illicit cannabis market with a legal […]The post Cannabis Stock News Daily Roundup July 5 appeared first on Market Exclusive.

  • Market Exclusive

    Agripharm Wins Approval for Outdoor Cultivation License

    Canopy Rivers (TSXV: RIV) (OTC: CNPOF) announced that its portfolio company Agripharm Corp. received its outdoor cultivation license from Health Canada. Agripharm is co-owned by SLANG (CNSX: SLNG), Canopy Growth (NYSE: CGC) and Green House Holdings North America and received a strategic investment from Canopy Rivers. Canopy Rivers provided the capital to finance the build-out […]The post Agripharm Wins Approval for Outdoor Cultivation License appeared first on Market Exclusive.

  • Baystreet

    Stocks in play: Canopy Rivers Inc.

    Says its 49%-owned joint venture PharmHouse Inc. has signed an offtake agreement with Canopy Growth ...

  • Meet the Canopy Growth (TSX:WEED) of Finance Stocks
    The Motley Fool

    Meet the Canopy Growth (TSX:WEED) of Finance Stocks

    Most people are aware that Canopy Growth Corp (TSX:RIV)(NYSE:RIV) is a leader in the cannabis space. What most don't know is that it has a strong partnership in finance.

  • Baystreet

    Where Beauty and Wellness are Being Significantly Disrupted by Cannabis

    Cannabis has become the New Gold Rush of 2019. Legalization in North America. Growing acceptance ...